Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2019 | Immunotherapy and targeted therapy for advanced aRCC

James Brugarolas, MD, PhD, from the University of Texas Southwestern Medical Center, Houston, TX, talks about immunotherapy for advanced renal cell carcinoma (aRCC). This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.